Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 423
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01685762 | Metformin for the Treatment of Endometrial Hyperplasia | ||
| NCT00998101 | Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy | ||
| NCT02690545 | Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL | ||
| NCT05483023 | 18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy | ||
| NCT03442569 | PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC | ||
| NCT06656936 | The PharmFIT Study | ||
| NCT01263418 | Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas | ||
| NCT05498220 | Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma | ||
| NCT05754749 | Comparison of CE-DBT and MRI in Patients With Known Breast Lesions | ||
| NCT00334438 | Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma | ||
| NCT01175967 | Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer | ||
| NCT07226271 | Consumer Perceptions of Alcoholic Beverages | ||
| NCT03454035 | Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors | ||
| NCT03077243 | P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC | ||
| NCT07553520 | Dietary Cysteine and Methionine Deprivation (CMD) in Glioma Patients | ||
| NCT05714982 | Impact of E-cigarette Device Warnings | ||
| NCT07214610 | Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study | ||
| NCT01305954 | Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients | ||
| NCT04076696 | Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis | ||
| NCT03820024 | MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback | ||
| NCT01845519 | Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors | ||
| NCT03885830 | Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients | ||
| NCT06848491 | Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors | ||
| NCT00312637 | Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease | ||
| NCT02003417 | Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy | ||
| NCT04292860 | Reverse Axillary Mapping in Breast Radiation Treatment Planning | ||
| NCT03907657 | Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau | ||
| NCT05542407 | ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer | ||
| NCT00182728 | Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer | ||
| NCT02175628 | Comparison of the Sensitivity and Specificity of Acoustic Angiography to the Sensitivity and Specificity of Conventional Ultrasound | ||
| NCT06158139 | Autologous CAR-T Cells Targeting B7-H3 in PDAC | ||
| NCT03424837 | A Survivorship Care Plan and Embedded Navigation Tool | ||
| NCT05911308 | Abequolixron (RGX-104) and Durvalumab in Lung Cancer | ||
| NCT01665703 | Imaging Correlates of Renal Cell Carcinoma Biological Features | ||
| NCT00006061 | Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency | ||
| NCT02574897 | The Ability of Electronic Patient Symptom Reporting to Reduce Symptom Burden During Hospitalization for Chemotherapy | ||
| NCT07599462 | Pilot Study of Communication for Dual Users of Cigarettes and E-cigarettes | ||
| NCT01204450 | Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma | ||
| NCT04585893 | Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi | ||
| NCT05722847 | Risk Stratification for Patients With Hospital-diagnosed Advanced Lung Cancer | ||
| NCT04920188 | Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML) | ||
| NCT00006110 | Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer | ||
| NCT01969370 | NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing | ||
| NCT00776126 | Digital Breast Tomosynthesis Preference Study | ||
| NCT01492881 | Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma | ||
| NCT03361800 | Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC | ||
| NCT01911247 | Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer | ||
| NCT02167932 | The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer | ||
| NCT02130947 | Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide | ||
| NCT01726738 | LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations |
